Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 226-250 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
Study aim:
Efficacy of tofacitinib in hospitalized patients with COVID-19
Design:
Patients are (...) and Imam Hossein Shahid Beheshti University of Medical Sciences of Tehran with a diagnosis of COVID-19(...) diagnosis of Covid-19 based on clinical findings and results of pulmonary CT-scan and who have developed
with Covid19
Design:
A clinical trial with a control group, parallel groups, one-way blind (...) : Acute or chronic renal failure with a definitive diagnosis of Covid19 admitted to the ward ,in the age over 18 years and lung involvement .
Exclusion criteria: previous history of COVID-19 and receiving
conduct:
Patients referred to Hazrat Vali Asr Hospital in Birjand with COVID19 infection whose disease (...) participate in the study
People over the age of 18
People with severe form of COVID-19 disease (shortness of (...) convalescent plasma for one turn Improved plasma for one turn in addition to the standard treatment of Covid-19
with covid-19
Design:
The sample size was estimated to be 84 people. Shit is divided into two groups (...) patients admitted to Sabzevar Vasei Hospital with a diagnosis of Covid-19.
All hospitalized patients with diagnosis of Covid19 who are in phase two (moderate or severe) of the disease are eligible to
stem cells conditioned media on covid -19 pneumonia
Design:
Includes 15 patients who will receive the (...) nebulized by nebulizer in 15 patients hospitalized with Covid19 for 5 days and in Used twice a day. One and (...) .
Participants/Inclusion and exclusion criteria:
Patients with Covid19 who have been infected for a week and who
Study aim:
Study of Tofacitinib effectiveness in the treatment of sever COVID-19 patients
Design:
ِDouble-blind, randomized clinical trial with parallel control group, phase 2-3 on 60 patients. Sealed (...) criteria: All patients with severe Covid-19 admitted to the ICU of Razi Hospital in Rasht from March to
Covid19
Design:
Clinical trial with control group, with parallel groups, double-blind, randomized (...) conduct:
Patients with Covid19 pneumonia admitted to Amir Al-Momenin Hospital of Arak city will be (...) normal,Covid19 positive pcr test, less than 93% oxygen saturation, respiratory rate less than 24 , CT
Study aim:
Evaluation of the effect of melatonin in patients with COVID-19-induced pneumonia (...) Abbas. The study population is 60 patients with COVID-19 (30 patients in control group and 30 in study (...)COVID-19 based on RT-PCR or/and serological testing, age >20 years, Diagnosis of pneumonia based on
Study aim:
Determining the effect of coconut oil supplement therapy in improving weakness and reducing the duration of patients with Covid-19
Design:
Clinical trial with control group, with parallel (...) registration system of Mashhad University of Medical Sciences, have been diagnosed with Covid19 and are under
Covid-19 pneumonia
Design:
A phase 2-3, placebo-controlled, paralleled, single-blind, randomized (...)COVID-19 (42 patients in treatment group and 42 in placebo group).
Participants/Inclusion and exclusion (...) for COVID-19, Hospitalized, and Signing informed consent and willingness of study participant to
, inflammatory and non-inflammatory markers in hospitalized Covid-19 patients compared with placebo
Design (...) .
Settings and conduct:
This study is a randomized clinical trial and patients admitted with Covid19 in (...) criteria:
Conscious consent
Hospitalized patients with Covid19
Age category 18 years and above
Exclusion
Study aim:
Study the effect of corticosteroid on the outpatient treatment Covid-19 patients
Design:
70 outpatient patients with covid-19 will be randomly assigned to intervention and control (placebo (...) criteria: definite case of Covid-19, age over 18, presented in day 5th-10th from the start of sign and
of Covid-19 mild to moderate symptoms
Design:
This clinical trial has a control group, and with (...) the routine treatment for COVID-19. Patients in the control group will receive routine treatment and (...) criteria: Patients with COVID-19 confirmed by RT-PCR and Ground glass view on CT scan; Patients with COVID
Study aim:
Study of Ivermectin effectiveness in the treatment of COVID-19 patients
Design:
Double-blind, randomized clinical trial with parallel control group, phase 2-3 on 60 patients.
Settings and (...) sealed envelope method.
Participants/Inclusion and exclusion criteria:
All Covid-19 patients admitted
Study aim:
The efficacy and safety of Ivermectin in patients with COVID-19
Design:
Controlled (...) Medical Sciences, Bandar Abbas.The study population is 60 patients with COVID-19 (30 patients in control (...) ≥20 years old (weight ≥35 kg); positive polymerase chain reaction (PCR) test for COVID-19; non
Study aim:
Evaluation of the efficacy and safety of Melatonin in patients with COVID-19
Design:
A (...) , Hormozgan University of Medical Sciences, Bandar Abbas.The study population is 60 patients with COVID-19 (30 (...) criteria: Age >20 years, positive polymerase chain reaction (PCR) test for COVID-19 or/and lung involvement
of patients with COVID-19 infections
Design:
This is a parallel design, single center, phase 3 (...) ®) as their treatment regimen for COVID-19.
Participants/Inclusion and exclusion criteria:
inclusion criteria: 1. >18 yrs old
2. PCR confirmation of COVID-19
3. Severe or critical diseases as: RR>30 breaths
Alafenamid in hospitalized patients with COVID-19
Design:
Clinical trial, with two arm parallel group (...) with Covid19 who are hospitalized in the ward and have moderate to severe severity. Patients were (...) -19 based on chest CT scan or positive PCR test for COVID-19; Requiring hospitalization; Patient's age
hospitalization in patients with mechanical ventilation with COVID-19 at Nekouei Hospital
Design:
A clinical (...)Covid-19 disease by infectious disease physician; Patients who are hospitalized in the intensive care (...) to the ventilator.
Non-inclusion: Patients with COVID19 but not Intubation
Intervention groups
Trachyspermum ammi, thymoquinone fraction of Nigella sativa and colchicine of Colchicum autumnale in COVID-19(...) /Inclusion and exclusion criteria:
Inclusion criteria are finding(s) in favor of COVID-19 in Chest CT scan when accompanied with the clinical sign(s) and symptom(s) or RT-PCR-confirmed for COVID-19 in the
oxygen saturation in patients with COVID-19
Design:
Patient candidate for with evidences of COVID-19 in (...) control group.
Settings and conduct:
Patients with evidences of COVID-19 in chest CT Scan and candidate (...) :
Patients with evidence of COVID-19 in Chest CT Scan
Without history of Asthma or Chronic Obstruction
Study aim:
Evaluating the efficacy of herbal products (capsule) in COVID-19 patients in a clinical (...) guidelines for diagnosis and treatment of COVID-19 disease that require hospitalization, and 50 patients (...) according to the national guidelines for diagnosis and treatment of COVID-19, and have completed an informed
manifestations of patients with probable or confirmed COVID-19
Design:
This study is a randomized controlled clinical trial on hospitalized patients with probable or confirmed COVID-19. Individuals with eligibility (...) University of Medical Sciences. This hospital has been assigned for COVID-19 patients. This research will be
patients with COVID-19 (2019-nCov) hospitalized in the intensive care unit
Design:
Clinical trial with (...) this study, people over the age of 18 with COVID-19 are randomly divided into two groups receiving (...) Infection from COVID-19, Age 18-65 years old, Tendency to participate in study
Non inclusion criteria: Covid